PolyPid (PYPD) PE Ratio: History & Chart

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T18:05:00.605Z.

Stored calculation inputs

Calculation as of: 2026-10-06T18:05:00.605Z.

Quote observation: 2026-10-06T17:59:30.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 5.19
Unrounded diluted TTM EPS · period ending 2026-06-30: -1.48

FMP input reference: d00a9c235f8f3f2200d332a4911885706ef223ec632fccfa45bb3326c1a5dd06

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

PYPD PE Ratio Metrics

PE RATIO

N/A

PYPD Competitors' PE Ratio

PYPD

PolyPid Ltd.

Current

Market Cap

$99.04M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CNXU

Conexeu Sciences Inc.

vs PYPD

Market Cap

$98.07M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MIST

Milestone Pharmaceuticals Inc.

vs PYPD

Market Cap

$97.30M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KRRO

Korro Bio, Inc.

vs PYPD

Market Cap

$97.24M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

JYNT

The Joint Corp.

vs PYPD

Market Cap

$102.35M

PE Ratio

27.08

TTM Avg

39.41

3Y Avg

48.57

5Y Avg

115.64

OKUR

OnKure Therapeutics, Inc.

vs PYPD

Market Cap

$103.27M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PLYX

Polaryx Therapeutics, Inc. Common Stock

vs PYPD

Market Cap

$103.68M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ANIX

Anixa Biosciences, Inc.

vs PYPD

Market Cap

$104.96M

PE Ratio

N/A

TTM Avg

597.78

3Y Avg

597.78

5Y Avg

597.78

DH

Definitive Healthcare Corp.

vs PYPD

Market Cap

$105.20M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PARK

Park Dental Partners, Inc. Common Stock

vs PYPD

Market Cap

$92.33M

PE Ratio

N/A

TTM Avg

13.33

3Y Avg

13.33

5Y Avg

13.33

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
PolyPid Ltd. (PYPD)	$99.04M	N/A	N/A	N/A	N/A
Conexeu Sciences Inc. (CNXU)vs ›	$98.07M	N/A	N/A	N/A	N/A
Milestone Pharmaceuticals Inc. (MIST)vs ›	$97.30M	N/A	N/A	N/A	N/A
Korro Bio, Inc. (KRRO)vs ›	$97.24M	N/A	N/A	N/A	N/A
The Joint Corp. (JYNT)vs ›	$102.35M	27.08	39.41	48.57	115.64
OnKure Therapeutics, Inc. (OKUR)vs ›	$103.27M	N/A	N/A	N/A	N/A
Polaryx Therapeutics, Inc. Common Stock (PLYX)vs ›	$103.68M	N/A	N/A	N/A	N/A
Anixa Biosciences, Inc. (ANIX)vs ›	$104.96M	N/A	597.78	597.78	597.78
Definitive Healthcare Corp. (DH)vs ›	$105.20M	N/A	N/A	N/A	N/A
Park Dental Partners, Inc. Common Stock (PARK)vs ›	$92.33M	N/A	13.33	13.33	13.33

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$5.19

÷

Forward EPS (Est.)

$-1.67

=

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

PYPD PE Ratio Metrics

PYPD Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics